Changes in eGFR in patients treated with TDF or ABC between baseline and 96 weeks.

Baseline demographics and laboratory data of patients who received tenofovir- and abacavir-based antiretroviral therapy (n = 503).

Takeshi Nishijima (212471)
Hiroyuki Gatanaga (205448)
Hirokazu Komatsu (209445)
Kunihisa Tsukada (212489)
Takuro Shimbo (159443)
Takahiro Aoki (212477)
Koji Watanabe (205444)
Ei Kinai (212480)
Haruhito Honda (212482)
Junko Tanuma (205450)
Hirohisa Yazaki (212487)
Miwako Honda (212491)
Katsuji Teruya (212494)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

February 2013

TDF: tenofovir, ABC: abacavir, IQR: interquartile range, BMI: body mass index, eGFR: estimated gl...

Continuous change in serum eGFR during 240 weeks of combined therapy.

Ming-Tsung Lin (2559364)
Yi-Hao Yen (837269)
Ming-Chao Tsai (544594)
Po-Lin Tseng (544595)
Kuo-Chin Chang (544593)
Cheng-Kun Wu (405048)
Tsung-Hui Hu (349887)

November 2016

During 144 weeks of combined therapy, the LdT+ADV group had a higher eGFR than the LAM+ADV group ...

Changes in eGFR for (A) all patients (n = 40), and those evaluated at (B) 3 months after discharge (n = 11), (C) 6 months after discharge (n = 2), (D) 9 months after discharge (n = 6), and (E) 12 months after discharge (n = 21).

Wen-Ling Lin (575107)
Chen-June Seak (575108)
Jiunn-Yih Wu (575109)
Yi-Ming Weng (575110)
Hang-Cheng Chen (575111)

June 2014

Changes in eGFR for (A) all patients (n = 40), and those evaluated at (B) 3 months after discharg...

Kaplan-Meier curve showing the time to renal dysfunction in patients treated with TDF or ABC.

Takeshi Nishijima (212471)
Hiroyuki Gatanaga (205448)
Hirokazu Komatsu (209445)
Kunihisa Tsukada (212489)
Takuro Shimbo (159443)
Takahiro Aoki (212477)
Koji Watanabe (205444)
Ei Kinai (212480)
Haruhito Honda (212482)
Junko Tanuma (205450)
Hirohisa Yazaki (212487)
Miwako Honda (212491)
Katsuji Teruya (212494)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

February 2013

Compared to treatment-naïve patients who commenced treatment with ABC, those on TDF were more lik...

Multivariate analysis to estimate the risk of TDF- over ABC-based antiretroviral therapy in inducing more than 25% fall in eGFR.

Takeshi Nishijima (212471)
Hiroyuki Gatanaga (205448)
Hirokazu Komatsu (209445)
Kunihisa Tsukada (212489)
Takuro Shimbo (159443)
Takahiro Aoki (212477)
Koji Watanabe (205444)
Ei Kinai (212480)
Haruhito Honda (212482)
Junko Tanuma (205450)
Hirohisa Yazaki (212487)
Miwako Honda (212491)
Katsuji Teruya (212494)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

February 2013

†P<0.05 in Model 3.TDF: tenofovir, ABC: abacavir, eGFR: estimated glomerular filtration ra...

Average estimated glomerular filtration rate in patients during and after telaprevir therapy, by baseline kidney function.

Meghan E. Sise (731751)
Elke S. Backman (731752)
Julia B. Wenger (250274)
Brian R. Wood (298606)
Paul E. Sax (242203)
Raymond T. Chung (214536)
Ravi Thadhani (367097)
Arthur Y. Kim (565877)

April 2015

3a. Baseline eGFR ≥ 90 mL/min/1.73m2 3b. Baseline eGFR < 90 mL/min/1.73m2. ...

Changes of renal function-associated indicators among tenofovir, telbivudine and entecavir groups before and after treatment.

Ming-Chao Tsai (544594)
Chien-Hung Chen (367115)
Po-Lin Tseng (544595)
Chao-Hung Hung (349882)
King-Wah Chiu (322977)
Kuo-Chin Chang (544593)
Yi-Hao Yen (837269)
Ming-Tsung Lin (2559364)
Tsung-Hui Hu (349887)

March 2016

(A) by serum creatinine (B) eGFR calculated by MDRD (C) eGFR calculated by CKD-EPI (D) eGFR calcu...

Change in eGFR levels over 3 years.

Hironari Hanaoka (3910738)
Harunobu Iida (3910741)
Tomofumi Kiyokawa (3910756)
Yukiko Takakuwa (3910747)
Takahiro Okazaki (3910750)
Hidehiro Yamada (398062)
Shoichi Ozaki (413554)
Kimito Kawahata (5171996)

May 2018

There was no difference in eGFR level between patients with antiplatelet therapy and those withou...

Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years

Grignolo, Sara
Tatarelli, Paola
Gustinetti, Giulia
Viazzi, Francesca
Bonino, Barbara
Maggi, Paolo
Viscoli, Claudio
Di Biagio, Antonio

January 2015

The aim of this study is to describe longitudinal changes in estimated glomerular filtration rate (e...

Results from the MTC: Difference in mean change in eGFR from baseline at 48 weeks (using CG method).

Sandrine Cure (734643)
Florence Bianic (734644)
Caroline Espinas (734645)
Helene Hardy (734646)
Lisa Rosenblatt (734647)
Timothy Juday (734648)

May 2015

CG: Cockcroft–Gault; eGFR: estimated Glomerular Filtration Rate; MTC: Mixed-Treatment Comparison....

MTC results providing the difference in mean change in eGFR from baseline compared with ATV/r + TDF/FTC (CG method).

Sandrine Cure (734643)
Florence Bianic (734644)
Caroline Espinas (734645)
Helene Hardy (734646)
Lisa Rosenblatt (734647)
Timothy Juday (734648)

May 2015

95%CrIs: 95% Credible Intervals; CG: Cockcroft–Gault; eGFR: estimated Glomerular Filtration Rate;...

Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2\ua0years.

GRIGNOLO, SARA
TATARELLI, PAOLA
GUSTINETTI, GIULIA
VIAZZI, FRANCESCA CHIARA
Bonino, B
Maggi, P
VISCOLI, CLAUDIO
DI BIAGIO, ANTONIO

January 2015

The aim of this study is to describe longitudinal changes in estimated glomerular filtration rate (e...

Changes in the eGFR in the groups according to the eGFR at baseline (0 months) before and after the initiation of tofogliflozin (n = 102).

Hiroyuki Ito (339050)
Hideyuki Inoue (156340)
Takuma Izutsu (10305465)
Suzuko Matsumoto (10305462)
Shinichi Antoku (339057)
Tomoko Yamasaki (1898185)
Toshiko Mori (10305468)
Michiko Togane (339061)

September 2023

(A) The closed (black) circles and open (white) squares indicate subjects in the normal- (≥60 mL/min...

Changes in the eGFR in 102 patients treated over 12 months before the initiation of tofogliflozin administration.

Hiroyuki Ito (339050)
Hideyuki Inoue (156340)
Takuma Izutsu (10305465)
Suzuko Matsumoto (10305462)
Shinichi Antoku (339057)
Tomoko Yamasaki (1898185)
Toshiko Mori (10305468)
Michiko Togane (339061)

September 2023

Changes in the eGFR in 102 patients treated over 12 months before the initiation of tofogliflozin ad...

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter?

51. A. Vergori
R. Gagliardini
N. Gianotti
A. Gori
M. Lichtner
A. Saracino
A. De Vito
A. Cascio
A. Di Biagio
A. d’Arminio Monforte
A. Antinori
A. Cozzi-Lepri
on behalf of the ICONA Foundation Study Network
L. Chessa

January 2020

Our aim was to evaluate the association between recent eGFR values and risk of switching from TDF to...

Baseline demographics and laboratory data of patients who received tenofovir- and abacavir-based antiretroviral therapy (n = 503).

Takeshi Nishijima (212471)
Hiroyuki Gatanaga (205448)
Hirokazu Komatsu (209445)
Kunihisa Tsukada (212489)
Takuro Shimbo (159443)
Takahiro Aoki (212477)
Koji Watanabe (205444)
Ei Kinai (212480)
Haruhito Honda (212482)
Junko Tanuma (205450)
Hirohisa Yazaki (212487)
Miwako Honda (212491)
Katsuji Teruya (212494)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

February 2013

TDF: tenofovir, ABC: abacavir, IQR: interquartile range, BMI: body mass index, eGFR: estimated gl...

Continuous change in serum eGFR during 240 weeks of combined therapy.

Ming-Tsung Lin (2559364)
Yi-Hao Yen (837269)
Ming-Chao Tsai (544594)
Po-Lin Tseng (544595)
Kuo-Chin Chang (544593)
Cheng-Kun Wu (405048)
Tsung-Hui Hu (349887)

November 2016

During 144 weeks of combined therapy, the LdT+ADV group had a higher eGFR than the LAM+ADV group ...

Changes in eGFR for (A) all patients (n = 40), and those evaluated at (B) 3 months after discharge (n = 11), (C) 6 months after discharge (n = 2), (D) 9 months after discharge (n = 6), and (E) 12 months after discharge (n = 21).

Wen-Ling Lin (575107)
Chen-June Seak (575108)
Jiunn-Yih Wu (575109)
Yi-Ming Weng (575110)
Hang-Cheng Chen (575111)

June 2014

Changes in eGFR for (A) all patients (n = 40), and those evaluated at (B) 3 months after discharg...

Kaplan-Meier curve showing the time to renal dysfunction in patients treated with TDF or ABC.

Takeshi Nishijima (212471)
Hiroyuki Gatanaga (205448)
Hirokazu Komatsu (209445)
Kunihisa Tsukada (212489)
Takuro Shimbo (159443)
Takahiro Aoki (212477)
Koji Watanabe (205444)
Ei Kinai (212480)
Haruhito Honda (212482)
Junko Tanuma (205450)
Hirohisa Yazaki (212487)
Miwako Honda (212491)
Katsuji Teruya (212494)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

February 2013

Compared to treatment-naïve patients who commenced treatment with ABC, those on TDF were more lik...

Multivariate analysis to estimate the risk of TDF- over ABC-based antiretroviral therapy in inducing more than 25% fall in eGFR.

Takeshi Nishijima (212471)
Hiroyuki Gatanaga (205448)
Hirokazu Komatsu (209445)
Kunihisa Tsukada (212489)
Takuro Shimbo (159443)
Takahiro Aoki (212477)
Koji Watanabe (205444)
Ei Kinai (212480)
Haruhito Honda (212482)
Junko Tanuma (205450)
Hirohisa Yazaki (212487)
Miwako Honda (212491)
Katsuji Teruya (212494)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

February 2013

†P<0.05 in Model 3.TDF: tenofovir, ABC: abacavir, eGFR: estimated glomerular filtration ra...

Average estimated glomerular filtration rate in patients during and after telaprevir therapy, by baseline kidney function.

Meghan E. Sise (731751)
Elke S. Backman (731752)
Julia B. Wenger (250274)
Brian R. Wood (298606)
Paul E. Sax (242203)
Raymond T. Chung (214536)
Ravi Thadhani (367097)
Arthur Y. Kim (565877)

April 2015

3a. Baseline eGFR ≥ 90 mL/min/1.73m2 3b. Baseline eGFR < 90 mL/min/1.73m2. ...

Changes of renal function-associated indicators among tenofovir, telbivudine and entecavir groups before and after treatment.

Ming-Chao Tsai (544594)
Chien-Hung Chen (367115)
Po-Lin Tseng (544595)
Chao-Hung Hung (349882)
King-Wah Chiu (322977)
Kuo-Chin Chang (544593)
Yi-Hao Yen (837269)
Ming-Tsung Lin (2559364)
Tsung-Hui Hu (349887)

March 2016

(A) by serum creatinine (B) eGFR calculated by MDRD (C) eGFR calculated by CKD-EPI (D) eGFR calcu...

Change in eGFR levels over 3 years.

Hironari Hanaoka (3910738)
Harunobu Iida (3910741)
Tomofumi Kiyokawa (3910756)
Yukiko Takakuwa (3910747)
Takahiro Okazaki (3910750)
Hidehiro Yamada (398062)
Shoichi Ozaki (413554)
Kimito Kawahata (5171996)

May 2018

There was no difference in eGFR level between patients with antiplatelet therapy and those withou...

Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years

Grignolo, Sara
Tatarelli, Paola
Gustinetti, Giulia
Viazzi, Francesca
Bonino, Barbara
Maggi, Paolo
Viscoli, Claudio
Di Biagio, Antonio

January 2015

The aim of this study is to describe longitudinal changes in estimated glomerular filtration rate (e...

Results from the MTC: Difference in mean change in eGFR from baseline at 48 weeks (using CG method).

Sandrine Cure (734643)
Florence Bianic (734644)
Caroline Espinas (734645)
Helene Hardy (734646)
Lisa Rosenblatt (734647)
Timothy Juday (734648)

May 2015

CG: Cockcroft–Gault; eGFR: estimated Glomerular Filtration Rate; MTC: Mixed-Treatment Comparison....

MTC results providing the difference in mean change in eGFR from baseline compared with ATV/r + TDF/FTC (CG method).

Sandrine Cure (734643)
Florence Bianic (734644)
Caroline Espinas (734645)
Helene Hardy (734646)
Lisa Rosenblatt (734647)
Timothy Juday (734648)

May 2015

95%CrIs: 95% Credible Intervals; CG: Cockcroft–Gault; eGFR: estimated Glomerular Filtration Rate;...

Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2\ua0years.

GRIGNOLO, SARA
TATARELLI, PAOLA
GUSTINETTI, GIULIA
VIAZZI, FRANCESCA CHIARA
Bonino, B
Maggi, P
VISCOLI, CLAUDIO
DI BIAGIO, ANTONIO

January 2015

The aim of this study is to describe longitudinal changes in estimated glomerular filtration rate (e...

Changes in the eGFR in the groups according to the eGFR at baseline (0 months) before and after the initiation of tofogliflozin (n = 102).

Hiroyuki Ito (339050)
Hideyuki Inoue (156340)
Takuma Izutsu (10305465)
Suzuko Matsumoto (10305462)
Shinichi Antoku (339057)
Tomoko Yamasaki (1898185)
Toshiko Mori (10305468)
Michiko Togane (339061)

September 2023

(A) The closed (black) circles and open (white) squares indicate subjects in the normal- (≥60 mL/min...

Changes in the eGFR in 102 patients treated over 12 months before the initiation of tofogliflozin administration.

Hiroyuki Ito (339050)
Hideyuki Inoue (156340)
Takuma Izutsu (10305465)
Suzuko Matsumoto (10305462)
Shinichi Antoku (339057)
Tomoko Yamasaki (1898185)
Toshiko Mori (10305468)
Michiko Togane (339061)

September 2023

Changes in the eGFR in 102 patients treated over 12 months before the initiation of tofogliflozin ad...

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter?

51. A. Vergori
R. Gagliardini
N. Gianotti
A. Gori
M. Lichtner
A. Saracino
A. De Vito
A. Cascio
A. Di Biagio
A. d’Arminio Monforte
A. Antinori
A. Cozzi-Lepri
on behalf of the ICONA Foundation Study Network
L. Chessa

January 2020

Our aim was to evaluate the association between recent eGFR values and risk of switching from TDF to...

Baseline demographics and laboratory data of patients who received tenofovir- and abacavir-based antiretroviral therapy (n = 503).

Takeshi Nishijima (212471)
Hiroyuki Gatanaga (205448)
Hirokazu Komatsu (209445)
Kunihisa Tsukada (212489)
Takuro Shimbo (159443)
Takahiro Aoki (212477)
Koji Watanabe (205444)
Ei Kinai (212480)
Haruhito Honda (212482)
Junko Tanuma (205450)
Hirohisa Yazaki (212487)
Miwako Honda (212491)
Katsuji Teruya (212494)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

February 2013

TDF: tenofovir, ABC: abacavir, IQR: interquartile range, BMI: body mass index, eGFR: estimated gl...

Continuous change in serum eGFR during 240 weeks of combined therapy.

Ming-Tsung Lin (2559364)
Yi-Hao Yen (837269)
Ming-Chao Tsai (544594)
Po-Lin Tseng (544595)
Kuo-Chin Chang (544593)
Cheng-Kun Wu (405048)
Tsung-Hui Hu (349887)

November 2016

During 144 weeks of combined therapy, the LdT+ADV group had a higher eGFR than the LAM+ADV group ...

Changes in eGFR for (A) all patients (n = 40), and those evaluated at (B) 3 months after discharge (n = 11), (C) 6 months after discharge (n = 2), (D) 9 months after discharge (n = 6), and (E) 12 months after discharge (n = 21).

Wen-Ling Lin (575107)
Chen-June Seak (575108)
Jiunn-Yih Wu (575109)
Yi-Ming Weng (575110)
Hang-Cheng Chen (575111)

June 2014

Changes in eGFR for (A) all patients (n = 40), and those evaluated at (B) 3 months after discharg...

Changes in eGFR in patients treated with TDF or ABC between baseline and 96 weeks.

Abstract

Extracted data

Changes in eGFR in patients treated with TDF or ABC between baseline and 96 weeks.

Abstract

Extracted data

Related items

Related items